Depo-Provera Lawsuit Texas 2026: State Rights, Deadlines & How to File
Update — September 24, 2026: A settlement has been reached. On June 15, 2026, plaintiffs’ leadership counsel announced a settlement with Pfizer of a majority of the claims in Depo-Provera MDL 3140 — before Judge M. Casey Rodgers in the U.S. District Court for the Northern District of Florida — and in New York state court. The parties signed a confidential Master Settlement Agreement on July 21, 2026.
No financial terms have been disclosed — no aggregate, per-plaintiff or per-tier figure has been released. Because the MDL is not a class action, the settlement is not subject to a court fairness determination. The parties estimate roughly 80% of MDL plaintiffs are eligible, and the deadline for claimants to register for the Settlement Program is November 30, 2026. With the announcement, the court cancelled the December 2026 trial in the first Pilot case (Toney v. Pfizer). See our Depo-Provera settlement amounts guide for current status.
SourceN.D. Fla. CMO 1227 Jul 2026N.D. Fla. CMO 1410 Aug 2026
Find out if you may have a claim
Answer a few questions and a trained case advisor will review your situation — most people finish in about a minute.
- Free — no cost, no obligation
- About a minute to complete
- Reviewed by a trained case advisor
- Nothing you submit is published
Your details are sent over a secure connection and reviewed confidentially.
Depo-Provera Lawsuit Texas 2026: Eligibility, Deadlines and How to File
If you live in Texas and developed an intracranial meningioma after receiving Depo-Provera or a generic depot medroxyprogesterone acetate injection, a Depo-Provera Lawsuit Texas review may help determine whether you can join the federal litigation.
This Texas-focused guide explains how MDL No. 3140 works, how Texas filing deadlines may apply, what records attorneys review, and how a Depo-Provera Lawsuit Texas claim may be evaluated for settlement purposes.
Quick Answer: Depo-Provera Lawsuit Texas
A Depo-Provera Lawsuit Texas claim generally involves a Texas resident who received Depo-Provera or generic depot medroxyprogesterone acetate and was later diagnosed with an intracranial meningioma. The official MDL page identifies MDL No. 3140 in the Northern District of Florida and describes allegations that Depo-Provera or generic equivalents can cause users to develop meningiomas.
- Core injury: Intracranial meningioma after Depo-Provera or generic DMPA use.
- Texas deadline issue: Texas generally uses a two-year personal injury limitations period, but discovery issues can matter.
- Federal court: Many claims are coordinated in MDL No. 3140 before Judge M. Casey Rodgers.
- Important hearing: The federal court lists the Rule 702 motions hearing for September 18, 2026, following that day’s case management conference.
- Settlement: A settlement covering a majority of MDL claims was announced on June 15, 2026; the deadline for claimants to register for the Settlement Program is November 30, 2026.
- Claim documents: Injection records, imaging reports, pathology, treatment records, and diagnosis timelines.
- Free review: A Depo-Provera Lawsuit Texas attorney review can check exposure, diagnosis, deadlines, and case value factors.
SourceN.D. Fla. MDL 3140N.D. Fla. CMO 1227 Jul 2026N.D. Fla. CMO 1410 Aug 2026Tex. CPRC § 16.003Current law
Depo-Provera Lawsuit Texas Overview
The Depo-Provera Lawsuit Texas topic is important because Texas residents may have both federal MDL issues and Texas-specific filing questions. The federal proceeding coordinates discovery, expert challenges, case management, and bellwether preparation, but a Texas claimant’s filing deadline, damages proof, medical records, and personal history still matter.
Depo-Provera is an injectable contraceptive containing medroxyprogesterone acetate. Plaintiffs in the federal litigation allege that long-term or repeated use may increase the risk of meningioma, a tumor that develops from the membranes surrounding the brain and spinal cord. Defendants dispute liability, causation, and other claims, which is why expert evidence is central to the case.
A Depo-Provera Lawsuit Texas review is not the same as a class action signup. Most mass tort claimants need individualized records showing their injection history, medical diagnosis, treatment, damages, and timing. Texas residents should not assume that simply living in Texas protects their deadline; state law and discovery facts must be reviewed quickly.
Who May Qualify for a Depo-Provera Lawsuit in Texas?
Eligibility for a Depo-Provera Lawsuit Texas claim depends on medical and prescription evidence. A claimant usually needs documented Depo-Provera or generic DMPA exposure and a later meningioma diagnosis. The strongest claims often have repeated injections, clear diagnosis records, and symptoms or treatment that show meaningful harm.
Injection History
Attorneys look for pharmacy records, clinic records, OB-GYN records, Medicaid records, or other proof showing Depo-Provera or generic DMPA injections.
Meningioma Diagnosis
MRI, CT, pathology, neurology, neurosurgery, radiation, monitoring, and hospital records can document the meningioma diagnosis and treatment course.
Deadline Review
Texas limitations rules may depend on diagnosis date, discovery date, warning awareness, and individual medical facts. Do not wait to request review.
A person who did not have surgery may still request a Depo-Provera Lawsuit Texas evaluation if she has a confirmed meningioma diagnosis. Surgery can affect damages, but it is not the only factor. Watchful waiting, radiation, recurring scans, lost income, cognitive changes, vision issues, seizures, and quality-of-life effects may also matter.
For a broader eligibility checklist, review TortAdvisor’s Depo-Provera eligibility guide and compare your facts with the main Depo-Provera lawsuit overview.
Texas Statute of Limitations for Depo-Provera Claims
A Depo-Provera Lawsuit Texas deadline can be complicated. Texas Civil Practice and Remedies Code Section 16.003 generally gives a two-year period for personal injury claims. In latent injury cases, however, plaintiffs often need a careful discovery-rule analysis to determine when the claim accrued.
That means the relevant date may not be as simple as the first injection date. A lawyer may review when the meningioma was diagnosed, when the claimant learned or reasonably should have learned of a potential connection to Depo-Provera, and whether medical records or warnings affected discovery. Because these issues are fact-sensitive, Texas residents should get a deadline review immediately.
How Texas Claims Fit Into MDL No. 3140
A Depo-Provera Lawsuit Texas claim may be filed or transferred into the federal MDL for coordinated pretrial proceedings. MDL centralization does not mean every claimant receives the same outcome. Instead, the process can streamline discovery, expert motions, common evidence, pretrial orders, and bellwether trial planning.
The Northern District of Florida’s MDL page lists the case as In Re: Depo-Provera Products Liability Litigation, MDL No. 3140. The court’s page lists the Rule 702 motions hearing for September 18, 2026, following that day’s case management conference; it was originally set for June 24–25, 2026 and was moved first to July 27. Rule 702 governs expert testimony, and the rulings will apply to cases outside the settlement rather than to plaintiffs who are eligible for it and participate.
SourceN.D. Fla. MDL 3140N.D. Fla. PTO 30A15 Jun 2026N.D. Fla. CMO 1227 Jul 2026
For Texas claimants, the MDL process may decide common scientific and procedural issues, while individual facts remain important. A settlement covering a majority of MDL claims was announced on June 15, 2026. Cases that are ineligible or opt out continue under Case Management Order No. 14 and can proceed through later stages based on venue, trial selection, remand, or other court orders. A Depo-Provera Lawsuit Texas lawyer can explain how a Texas claim may be filed, transferred, tolled, or otherwise preserved.
SourceN.D. Fla. CMO 1227 Jul 2026N.D. Fla. CMO 1410 Aug 2026
Depo-Provera Lawsuit Texas Settlement Value Factors
A settlement covering a majority of the claims in MDL No. 3140 and New York state court was announced on June 15, 2026, and the parties signed a confidential Master Settlement Agreement on July 21, 2026. No financial terms have been disclosed, so any Depo-Provera Lawsuit Texas settlement estimate is not a published figure. The value of any claim depends on injury severity, proof of injections, timing, medical treatment, economic losses, and litigation developments.
SourceN.D. Fla. CMO 1227 Jul 2026
| Claim Factor | Why It Matters | Examples of Helpful Proof |
|---|---|---|
| Exposure | Repeated or long-term DMPA exposure may support causation arguments. | Clinic records, pharmacy records, OB-GYN notes, Medicaid records. |
| Diagnosis | Meningioma confirmation is central to the claim. | MRI, CT, pathology, neurology, neurosurgery records. |
| Treatment | Surgery, radiation, monitoring, or neurological symptoms can affect damages. | Hospital bills, procedure notes, scan history, specialist reports. |
| Texas damages | Lost wages, medical bills, pain, suffering, and long-term care can affect value. | Pay records, bills, insurance records, caregiver records. |
Use TortAdvisor’s settlement calculator hub for an educational estimate, then compare it with the Depo-Provera settlement amounts guide. A Depo-Provera Lawsuit Texas claim should still be reviewed by an attorney before any settlement range is relied on.
How to File a Depo-Provera Lawsuit Texas Claim
To start a Depo-Provera Lawsuit Texas review, gather your injection records, diagnosis records, and treatment timeline. You do not need to travel to Florida to ask whether your facts may qualify. A legal intake can begin with basic information about where you received injections, when your meningioma was diagnosed, and what treatment you received.
- Request a free review: Call 855-664-8713 or use the TortAdvisor intake process.
- Confirm injection history: Identify clinics, doctors, pharmacies, insurance records, or Medicaid records.
- Confirm diagnosis: Locate MRI, CT, neurology, pathology, or neurosurgery documents.
- Check Texas deadlines: Review diagnosis date, discovery date, and state-law deadline issues.
- Preserve the claim: If eligible, counsel can explain filing in or coordination with MDL No. 3140.
Because the Depo-Provera Lawsuit Texas process involves both federal coordination and Texas-specific facts, the safest approach is to request a review before the deadline becomes disputed.
Still unsure where you stand?
Have a trained case advisor review your own facts — free, confidential, and with no obligation.
- Free — no cost, no obligation
- About a minute to complete
- Reviewed by a trained case advisor
- Nothing you submit is published
Your details are sent over a secure connection and reviewed confidentially.
Depo-Provera Lawsuit Texas FAQ
Can Texas residents join the federal Depo-Provera MDL?
Yes. A Texas resident may be eligible for federal MDL coordination if the claim involves Depo-Provera or generic DMPA exposure and a later meningioma diagnosis. A Depo-Provera Lawsuit Texas review should also evaluate Texas filing deadlines.
SourceN.D. Fla. MDL 3140
What is the Texas deadline for filing?
Texas generally has a two-year personal injury limitations period, but latent-injury discovery facts can affect the analysis. Do not rely on a general online deadline; ask for a claim-specific Depo-Provera Lawsuit Texas review. Separately, the deadline for claimants to register for the MDL Settlement Program is November 30, 2026.
SourceTex. CPRC § 16.003Current lawN.D. Fla. CMO 1410 Aug 2026
Do I need surgery to qualify?
No. Surgery can increase damages in some cases, but people with confirmed meningiomas managed through monitoring, medication, or radiation may still request review.
How many cases are pending?
As of October 1, 2026, the Judicial Panel on Multidistrict Litigation reported 6,412 actions pending in MDL No. 3140. The JPML updates these figures monthly.
SourceJPML MDL report1 Sep 2026
What records should I collect?
Collect injection records, diagnosis records, imaging, pathology, surgical records, bills, lost-income documents, and the names of doctors or clinics that treated you.
Is a Depo-Provera Lawsuit Texas claim guaranteed to settle?
No. A settlement covering a majority of MDL claims was announced on June 15, 2026, but eligibility is set by the confidential Master Settlement Agreement, and cases outside it continue in litigation. The value and outcome of any Depo-Provera Lawsuit Texas claim depends on evidence, eligibility, individual damages and, for cases outside the settlement, expert rulings and defenses.
Sources and Citations
These sources support the MDL schedule, Texas limitations discussion, FDA label context, and medical-science background discussed in this Depo-Provera Lawsuit Texas guide.
- U.S. District Court, Northern District of Florida — Depo-Provera Products Liability Litigation, MDL No. 3140
- U.S. District Court, Northern District of Florida — Important Hearing Dates and Rule 702 Motions Hearing
- U.S. District Court, Northern District of Florida — MDL No. 3140 Orders by Date
- Texas Civil Practice and Remedies Code Section 16.003
- FDA Prescribing Information — Depo-Provera / Medroxyprogesterone Acetate Meningioma Warning
- PubMed — Depot Medroxyprogesterone Acetate and Risk of Meningioma
- Judicial Panel on Multidistrict Litigation — Pending MDL Dockets by Actions Pending (October 1, 2026)
- U.S. District Court, Northern District of Florida — Pretrial Order No. 30A (June 15, 2026)
- U.S. District Court, Northern District of Florida — Case Management Order No. 12 (July 27, 2026)
- U.S. District Court, Northern District of Florida — Case Management Order No. 14, Settlement Program (August 10, 2026)
Request a Free Depo-Provera Lawsuit Texas Review
If you were diagnosed with meningioma after Depo-Provera or generic DMPA injections, do not wait to check your Texas deadline. A confidential Depo-Provera Lawsuit Texas review can help evaluate records, timing, eligibility, and possible next steps.
Related Posts
The Supreme Court's June 25, 2026 ruling in Monsanto v. Durnell held that FIFRA can preempt state failure-to-warn claims, unsettling a central theory in paraquat cases. With 6,666 actions pending in MDL 3004 and a global settlement agreed in principle but no terms disclosed, here is what is verified and what is not.
Quick Answer: The Suboxone dental injury lawsuit update for August 2026 centers on MDL 3092, the federal litigation involving claims [...]
Quick Answer: The Depo-Provera lawsuit statute of limitations typically runs one to six years from the date of diagnosis, depending [...]
